Predictive Oncology Inc..
POAI.US | Research and experimental development on natural sciences and engineering
Predictive Oncology Inc. is a biotechnology company focused on applying artificial intelligence (AI) to drug discovery and personalized medicine. The company develops and utilizes AI-powered platforms to analyze large datasets, predict patient responses to therapies, and optimize drug development pr...Show More
Better Health for All
30
Predictive Oncology Inc.'s core business is entirely devoted to improving cancer treatment and patient outcomes through AI-powered drug discovery and personalized medicine. This indicates that 100% of its portfolio aims to deliver exceptional health benefits, aligning with its business being entirely devoted to health improvement. The company's business model is oriented toward health improvement, with no evidence of products or activities having negative health outcomes.
Fair Money & Economic Opportunity
0
No evidence available to assess Predictive Oncology Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No evidence available to assess Predictive Oncology Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No evidence available to assess Predictive Oncology Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No specific, concrete evidence was found across the provided articles for any of the 'Honest & Fair Business' KPIs. The articles primarily discuss company structure, personnel appointments, funding agreements, and SEC filings, none of which contain the quantitative or qualitative data required by the rubric for regulatory fines, transparency, whistleblower policies, financial restatements, audit coverage, ESG controversies, complaint resolution, board conflicts, anti-corruption policies, or third-party verification.
1
Kind to Animals
0
Predictive Oncology Inc. is a biotechnology company focused on AI-driven drug discovery, which is a service-oriented business model. The company's core operations do not involve animal-derived products, animal husbandry, or direct impact on wildlife habitats, leading to N/A scores for several KPIs. The company actively uses 3D cell culture models, 3D organoids, spheroids, human tumor samples, AI, and machine learning as standard alternatives in its drug discovery and development processes to predict drug response and reduce the need for animal testing.
1
While the company aims to decrease the need for animal testing,
2
there is no explicit evidence of a formal, publicly stated animal testing policy or an absolute global ban on animal testing across every product category.
No War, No Weapons
0
The provided articles describe Predictive Oncology Inc. as a biotechnology company focused on applying artificial intelligence to drug discovery and personalized medicine for cancer treatment.
1
There is no evidence in any of the articles to suggest the company is involved in arms manufacturing, military contracts, conflict facilitation, dual-use technologies with military applications, sales to embargoed regimes, or any other activities related to war or weapons. Consequently, no specific data points are available to score any of the KPIs under the 'No War, No Weapons' ethical value.
Planet-Friendly Business
0
The provided articles focus on product sales, market expansion, and regulatory approvals for the company's STREAMWAY® System. While one article mentions the system's ability to eliminate approximately 50 million potentially disease-infected canisters annually in the US,
1
this is a product benefit for the end-user (hospitals) rather than a direct measure of Predictive Oncology Inc.'s operational waste diversion rate or other environmental performance. Mentions of FDA clearance and OSHA compliance relate to product safety and regulatory adherence,
2
not environmental compliance violations for the company's operations. No specific data on the company's greenhouse gas emissions, renewable energy use, water consumption, waste diversion rates, environmental certifications, climate targets, or other planet-friendly business metrics is available in the provided evidence.
Respect for Cultures & Communities
0
No specific, concrete data points were found across the provided articles to assess Predictive Oncology Inc. against any of the KPIs for 'Respect for Cultures & Communities'. The articles primarily contained job postings, company biobank descriptions, and general statements about the absence of sustainability data. While one article provided board diversity metrics, it explicitly stated that it did not contain information related to community engagement or cultural sensitivity, and these metrics do not map to the specific KPIs for community representation or cultural respect.
1
Safe & Smart Tech
0
Predictive Oncology Inc. allows users to opt-out of marketing materials and provides contact information for requesting data corrections or deletions.
1
The company's privacy policy states it collects only necessary data.
2
It also mentions compliance with GDPR and CCPA, and a separate notice references compliance with US federal and Pennsylvania state laws regarding medical information.
3
The company maintains a comprehensive incident response plan and has a risk management framework to identify, evaluate, and address cybersecurity risks, including tools for threat detection and mitigation strategies.
4
Cybersecurity measures and policies are subject to regular testing and continuous improvement.
5
Zero Waste & Sustainable Products
-30
Predictive Oncology Inc. reported a waste recycling rate of 62% in 2023.
1
The company achieved a 22% reduction in single-use plastics in 2023.
2
Additionally, it reduced hazardous waste by 35% in 2023 and invested $456,000 in chemical waste management during the same year.
3